|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
New Techniques to Increase Drug Candidate Survivability | ||||||||||||||||
January 23, 2001 | ||||||||||||||||
Strategic Research Institute, Somerset, New Jersey USA May 22-23, 2001 -Emerging Technologies in ADME & Predictive Tox -In-Silico Techniques for ADME -Novel Advances in Informatics -Data Management Tools for ADME & Toxicology -In Vitro Screening -Modeling & Computational Approaches for ADME & Toxicity -Emerging Technologies: Toxicogenomics/Proteomics/Genetics -HTP Toxicity Assays |
||||||||||||||||
Organized by: | Strategic Research Institute | |||||||||||||||
Invited Speakers: | Amgen R.W. Johnson Pfizer Wyeth Millennium Aventis AstraZeneca Bristol-Myers Camitro Xencor Novartis Schering Glaxo Dupont Arqule Pfizer Global R&D Quintiles among others... |
|||||||||||||||
Deadline for Abstracts: | FEBRUARY 8, 2001 | |||||||||||||||
Registration: | 1-800-599-4950, x245 outside USA call 212-967-0095, x245 |
|||||||||||||||
E-mail: | gpascual@srinstitute.com | |||||||||||||||
Posted by: | Glenn A. Pascual | |||||||||||||||
Host: | 12.3.58.10 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |